Sponsor pipeline

Eccogene clinical trial pipeline

Get alerts when Eccogene's trials change

4 active trials 3 recruiting 2 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
2
Phase 2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07288138 A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide… Metabolic Dysfunction-associated Steatohepatitis Recruiting 2026-10-09
NCT07505303 MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial Adult Obesity Active, Not Recruiting 2026-06-25
Phase 1
NCT07334080 ECC4703 Food Effect and Relative Bioavailability Study in Healthy Adult Participants Metabolic Dysfunction-Associated Steatohepatitis Recruiting 2026-09-10
NCT07726368 Study of ECC4703 With Sulfasalazine and Pitavastatin Non-alcoholic Fatty Liver Disease (NAFLD) Recruiting 2026-09-10

Disease areas by active trials

NASH / MASH (3) · Obesity (1)

Get alerts when Eccogene's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free